Article: Addition of idarucizumab to plasma samples containing dabigatran allows to use routine coagulation assays to diagnose hemostasis disorders

Your email address will not be published. Required fields are marked *

Your review *

Name *

Email *

Save my name, email, and website in this browser for the next time I comment.